The DPP-4 inhibitor sitagliptin improves glycaemic control and early-stage diabetic nephropathy in adolescents with type 1 diabetes using the MiniMed 780G advanced hybrid closed-loop system: a randomised controlled trial

Authors

Institutions

Publication Details

Journal
Diabetologia
Published
2024-09-14
DOI
https://doi.org/10.1007/s00125-024-06265-7
Citations
9
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
3.22

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The DPP-4 inhibitor sitagliptin improves glycaemic control and early-stage diabetic nephropathy in adolescents with type 1 diabetes using the MiniMed 780G advanced hybrid closed-loop system: a randomised controlled trial

Nancy Samir Elbarbary, Eman Abdel Rahman Ismail, Amal A. El-Kholy, Manal El‐Hamamsy et al.
9 citations
Diabetologia
Diabetes Treatment and Management
3.22
article

The DPP-4 inhibitor sitagliptin improves glycaemic control and early-stage diabetic nephropathy in adolescents with type 1 diabetes using the MiniMed 780G advanced hybrid closed-loop system: a randomised controlled trial

Nancy Samir Elbarbary, Eman Abdel Rahman Ismail, Amal A. El-Kholy, Manal El‐Hamamsy, Marwa Zaki Ibrahim
article en
9 citations

Abstract

No abstract available for this paper.
DiabetologiaVol. 67(12)
Ain Shams University (EG), Ahram Canadian University (EG)
Ain Shams University
Good health and well-being
Openalex Percentile: Top 7%
Diabetes Treatment and Management
3.22
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.